Nrf2 deficiency leads to behavioral, neurochemical and transcriptional changes in mice

Genes to Cells

Volumn 18, Issue 10, 2013, Pages 899-908

  Muramatsu, Hiroyuki ^a   Katsuoka, Fumiki ^b,c   Toide, Katsuo ^a   Shimizu, Yusuke ^a   Furusako, Shoji ^a   Yamamoto, Masayuki ^b  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NEUROTRANSMITTER; SEROTONIN; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN FUNCTION; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; FORCED SWIMMING TEST; GENE EXPRESSION; GENE TARGETING; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN DEFICIENCY; ROTAROD TEST; SEROTONERGIC TRANSMISSION; SOCIAL INTERACTION;

MUS;

AMINO ACIDS; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; DOPAMINE AGENTS; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHENOTYPE; ROTAROD PERFORMANCE TEST; SERINE; SEROTONIN AGENTS; SOCIAL BEHAVIOR;

EID: 84884816644     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12083     Document Type: Article

References (47)

1. Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K. & Yamamoto, M. (2001) Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 173, 154-160.
2. Baez, S., Segura-Aguilar, J., Widersten, M., Johansson, A.S. & Mannervik, B. (1997) Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem. J. 324, 25-28.
3. Bock, K.W. & Köhle, C. (2005) UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Methods Enzymol. 400, 57-75.
4. Burton, N.C., Kensler, T.W. & Guilarte, T.R. (2006) In vivo modulation of the Parkinsonian phenotype by Nrf2. Neurotoxicology 27, 1094-1100.
5. Chan, K., Han, X.D. & Kan, Y.W. (2001) An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc. Natl Acad. Sci. USA 98, 4611-4616.
6. Chanas, S.A., Jiang, Q., McMahon, M., McWalter, G.K., McLellan, L.I., Elcombe, C.R., Henderson, C.J., Wolf, C.R., Moffat, G.J., Itoh, K., Yamamoto, M. & Hayes, J.D. (2002) Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem. J. 15, 405-416.
7. Chauhan, A. & Chauhan, V. (2006) Oxidative stress in autism. Pathophysiology 13, 171-181.
8. Chen, P.C., Vargas, M.R., Pani, A.K., Smeyne, R.J., Johnson, D.A., Kan, Y.W. & Johnson, J.A. (2009) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc. Natl Acad. Sci. USA 106, 2933-2938.
9. Doze, V.A., Handel, E.M., Jensen, K.A., Darsie, B., Luger, E.J., Haselton, J.R., Talbot, J.N. & Rorabaugh, B.R. (2009) Alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. Brain Res. 1285, 148-157.
10. Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T. & Yamamoto, M. (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59, 169-177.
11. Gebel, S., Diehl, S., Pype, J., Friedrichs, B., Weiler, H., Schüller, J., Xu, H., Taguchi, K., Yamamoto, M. & Müller, T. (2010) The transcriptome of Nrf2-/- mice provides evidence for impaired cell cycle progression in the development of cigarette smoke-induced emphysematous changes. Toxicol. Sci. 115, 238-252.
12. Hirotsu, Y., Hataya, N., Katsuoka, F. & Yamamoto, M. (2012b) NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1β genes. Mol. Cell. Biol. 32, 2760-2770.
13. Hirotsu, Y., Katsuoka, F., Funayama, R., Nagashima, T., Nishida, Y., Nakayama, K., Engel, J.D. & Yamamoto, M. (2012a) Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res. 40, 10228-10239.
14. Iizuka, T., Ishii, Y., Itoh, K., Kiwamoto, T., Kimura, T., Matsuno, Y., Morishima, Y., Hegab, A.E., Homma, S., Nomura, A., Sakamoto, T., Shimura, M., Yoshida, A., Yamamoto, M. & Sekizawa, K. (2005) Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells 10, 1113-1125.
15. Innamorato, N.G., Jazwa, A., Rojo, A.I., García, C., Fernández-Ruiz, J., Grochot-Przeczek, A., Stachurska, A., Jozkowicz, A., Dulak, J. & Cuadrado, A. (2010) Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. PLoS ONE 5, e11838.
16. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M. & Nabeshima, Y. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322.
17. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D. & Yamamoto, M. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 76-86.
18. Jakel, R.J., Townsend, J.A., Kraft, A.D. & Johnson, J.A. (2007) Nrf2-mediated protection against 6-hydroxydopamine. Brain Res. 1144, 192-201.
19. Jin, W., Wang, H., Yan, W., Zhu, L., Hu, Z., Ding, Y. & Tang, K. (2009) Role of Nrf2 in protection against traumatic brain injury in mice. J. Neurotrauma 26, 131-139.
20. Katsuoka, F., Motohashi, H., Ishii, T., Aburatani, H., Engel, J.D. & Yamamoto, M. (2005) Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol. Cell. Biol. 25, 8044-8051.
21. Knight, T.R., Choudhuri, S. & Klaassen, C.D. (2007) Constitutive mRNA expression of various glutathione S-transferase isoforms in different tissues of mice. Toxicol. Sci. 100, 513-524.
22. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K. & Yamamoto, M. (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130-7139.
23. Kraft, A.D., Lee, J.M., Johnson, D.A., Kan, Y.W. & Johnson, J.A. (2006) Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element. J. Neurochem. 98, 1852-1865.
24. Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M. & Motohashi, H. (2012) Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22, 66-79.
25. Miyakawa, T., Leiter, L.M., Gerber, D.J., Gainetdinov, R.R., Sotnikova, T.D., Zeng, H., Caron, M.G. & Tonegawa, S. (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl Acad. Sci. USA 100, 8987-8992.
26. Mohn, A.R., Gainetdinov, R.R., Caron, M.G. & Koller, B.H. (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427-436.
27. Motohashi, H., O'Connor, T., Katsuoka, F., Engel, J.D. & Yamamoto, M. (2002) Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 294, 1-12.
28. Motohashi, H. & Yamamoto, M. (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10, 549-557.
29. Ng, F., Berk, M., Dean, O. & Bush, A.I. (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int. J. Neuropsychopharmacol. 11, 851-876.
30. Okamura, T., Katayama, T., Obinata, C., Iso, Y., Chiba, Y., Kobayashi, H., Yamada, Y., Harashima, H. & Minami, M. (2012) Neuronal injury induces microglial production of macrophage inflammatory protein-1α in rat corticostriatal slice cultures. J. Neurosci. Res. 90, 2127-2133.
31. O'Neill, M.F. & Conway, M.W. (2001) Role of 5-HT(1A) and 5-HT(1B) receptors in the mediation of behavior in the forced swim test in mice. Neuropsychopharmacology 24, 391-398.
32. Padmanabhan, B., Tong, K.I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.I., Kobayashi, A., Yokoyama, S. & Yamamoto, M. (2006) Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21, 689-700.
33. Paris, I., Lozano, J., Perez-Pastene, C., Muñoz, P. & Segura-Aguilar, J. (2009) Molecular and neurochemical mechanisms in PD pathogenesis. Neurotox. Res. 16, 271-279.
34. Porsolt, R.D., Bertin, A. & Jalfre, M. (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327-336.
35. Reiter, R.J. (1995) Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9, 526-533.
36. Rojo, A.I., Rada, P., Egea, J., Rosa, A.O., López, M.G. & Cuadrado, A. (2008) Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death. Mol. Cell. Neurosci. 39, 125-132.
37. Rosenberg, P.A. (1988) Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci. 8, 2887-2894.
38. Saeki, Y., Sakakibara, Y., Araki, Y., Yanagisawa, K., Suiko, M., Nakajima, H. & Liu, M.C. (1998) Molecular cloning, expression, and characterization of a novel mouse liver SULT1B1 sulfotransferase. J. Biochem. 124, 55-64.
39. Shah, Z.A., Li, R.C., Thimmulappa, R.K., Kensler, T.W., Yamamoto, M., Biswal, S. & Doré, S. (2007) Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury. Neuroscience 147, 53-59.
40. Shibata, T., Ohta, T., Tong, K.I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M. & Hirohashi, S. (2008) Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl Acad. Sci. USA 105, 13568-13573.
41. Shih, A.Y., Li, P. & Murphy, T.H. (2005) A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J. Neurosci. 25, 10321-10335.
42. Silverman, J.L., Yang, M., Lord, C. & Crawley, J.N. (2010) Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490-502.
43. Uutela, P., Reinilä, R., Harju, K., Piepponen, P., Ketola, R.A. & Kostiainen, R. (2009) Analysis of intact glucuronides and sulfates of serotonin, dopamine, and their phase I metabolites in rat brain microdialysates by liquid chromatography-tandem mass spectrometry. Anal. Chem. 81, 8417-8425.
44. Wrona, M.Z. & Dryhurst, G. (1998) Oxidation of serotonin by superoxide radical: implications to neurodegenerative brain disorders. Chem. Res. Toxicol. 11, 639-650.
45. Xu, Z., Cawthon, D., McCastlain, K.A., Slikker, W. Jr & Ali, S.F. (2005) Selective alterations of gene expression in mice induced by MPTP. Synapse 55, 45-51.
46. Yamada, J., Sugimoto, Y. & Yamada, S. (2004) Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur. J. Pharmacol. 504, 207-211.
47. Yao, J.K., Leonard, S. & Reddy, R. (2006) Altered glutathione redox state in schizophrenia. Dis. Markers 22, 83-93.